3DMed Diagnostic completed the first round of financing of 280 million RMB

China's leading bio-Tech company 3DMed recently completed its 280 million financing for its diagnostics business. After years of fast development, 3DMed has become the leader in the field of oncology precision diagnostic in China. It has two major business lines: LDT (laboratory developed test) and IVD (in vitro diagnostic) products

Related news
contact information
Questions or Comments